Bryan B. Gibson

865 total citations
9 papers, 637 citations indexed

About

Bryan B. Gibson is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Bryan B. Gibson has authored 9 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Psychiatry and Mental health and 4 papers in Oncology. Recurrent topics in Bryan B. Gibson's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Epilepsy research and treatment (2 papers). Bryan B. Gibson is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Epilepsy research and treatment (2 papers). Bryan B. Gibson collaborates with scholars based in United States and Switzerland. Bryan B. Gibson's co-authors include Jennifer L. Donovan, C. Lindsay DeVane, John S. Markowitz, Jun-Sheng Wang, Hao‐Jie Zhu, Holly A. Gefroh, Gary Williamson, Karen Cooper, Manuel Oliveira and Vanessa Crespy and has published in prestigious journals such as American Journal of Psychiatry, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Bryan B. Gibson

9 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan B. Gibson United States	8	167	156	155	137	95	9	637
Yasufumi Sawada Japan	10	72 0.4×	74 0.5×	71 0.5×	36 0.3×	126 1.3×	30	500
Gerardo Reyes-Garcı́a Mexico	20	196 1.2×	59 0.4×	64 0.4×	55 0.4×	38 0.4×	77	984
Aznan Lelo Indonesia	11	290 1.7×	60 0.4×	56 0.4×	43 0.3×	52 0.5×	50	727
J. Girault France	19	147 0.9×	26 0.2×	99 0.6×	46 0.3×	91 1.0×	47	1.2k
William D. Parsons Canada	9	272 1.6×	94 0.6×	169 1.1×	25 0.2×	52 0.5×	9	947
Augusto Filipe Spain	10	100 0.6×	34 0.2×	46 0.3×	51 0.4×	27 0.3×	38	607
Gerald Woollard New Zealand	17	162 1.0×	52 0.3×	294 1.9×	47 0.3×	26 0.3×	37	1.0k
M. Hümpel Germany	18	87 0.5×	192 1.2×	81 0.5×	68 0.5×	90 0.9×	53	1.1k
Susan E. Marino United States	18	187 1.1×	31 0.2×	404 2.6×	519 3.8×	90 0.9×	39	1.1k
Chuthamanee Suthisisang Thailand	16	158 0.9×	39 0.3×	58 0.4×	181 1.3×	52 0.5×	30	1.1k

Countries citing papers authored by Bryan B. Gibson

Since Specialization

Citations

This map shows the geographic impact of Bryan B. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan B. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan B. Gibson more than expected).

Fields of papers citing papers by Bryan B. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan B. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan B. Gibson. The network helps show where Bryan B. Gibson may publish in the future.

Co-authorship network of co-authors of Bryan B. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan B. Gibson. A scholar is included among the top collaborators of Bryan B. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan B. Gibson. Bryan B. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Zhu, Hao‐Jie, Jun-Sheng Wang, Jennifer L. Donovan, et al.. (2007). Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. European Journal of Pharmacology. 578(2-3). 148–158. 25 indexed citations

Newport, D. Jeffrey, Martha R. Calamaras, C. Lindsay DeVane, et al.. (2007). Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes. American Journal of Psychiatry. 164(8). 1214–1220. 162 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, John S. Markowitz, et al.. (2006). Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro. Neuropsychopharmacology. 32(4). 757–764. 77 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, Jennifer L. Donovan, et al.. (2006). Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization. Journal of Chromatography B. 846(1-2). 351–354. 34 indexed citations

Zhu, Haiyan, et al.. (2006). PI-35Sertraline and its metabolite desmethylsertraline, but not bupropion or its major metabolites, have high affinity for P-glycoprotein. Clinical Pharmacology & Therapeutics. 79(2). P16–P16. 1 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, John S. Markowitz, et al.. (2006). Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana. Journal of Pharmacology and Experimental Therapeutics. 317(2). 850–857. 140 indexed citations

Donovan, Jennifer L., Vanessa Crespy, Manuel Oliveira, et al.. (2006). (+)-Catechin is more bioavailable than (−)-catechin: Relevance to the bioavailability of catechin from cocoa. Free Radical Research. 40(10). 1029–1034. 101 indexed citations

Wang, Jun-Sheng, C. Lindsay DeVane, Bryan B. Gibson, et al.. (2005). Population pharmacokinetic analysis of drug–drug interactions among risperidone, bupropion, and sertraline in CF1 mice. Psychopharmacology. 183(4). 490–499. 40 indexed citations

Donovan, Jennifer L., C. Lindsay DeVane, Kenneth D. Chavin, et al.. (2004). MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS. Drug Metabolism and Disposition. 32(12). 1333–1336. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact